1. Home
  2. THRM vs GERN Comparison

THRM vs GERN Comparison

Compare THRM & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRM
  • GERN
  • Stock Information
  • Founded
  • THRM 1991
  • GERN 1990
  • Country
  • THRM United States
  • GERN United States
  • Employees
  • THRM N/A
  • GERN N/A
  • Industry
  • THRM Auto Parts:O.E.M.
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • THRM Consumer Discretionary
  • GERN Health Care
  • Exchange
  • THRM Nasdaq
  • GERN Nasdaq
  • Market Cap
  • THRM 1.0B
  • GERN 840.7M
  • IPO Year
  • THRM 1993
  • GERN 1996
  • Fundamental
  • Price
  • THRM $26.71
  • GERN $1.18
  • Analyst Decision
  • THRM Buy
  • GERN Buy
  • Analyst Count
  • THRM 3
  • GERN 9
  • Target Price
  • THRM $48.00
  • GERN $5.13
  • AVG Volume (30 Days)
  • THRM 536.1K
  • GERN 11.2M
  • Earning Date
  • THRM 04-24-2025
  • GERN 05-07-2025
  • Dividend Yield
  • THRM N/A
  • GERN N/A
  • EPS Growth
  • THRM 10.20
  • GERN N/A
  • EPS
  • THRM 1.59
  • GERN N/A
  • Revenue
  • THRM $1,453,963,000.00
  • GERN $116,293,000.00
  • Revenue This Year
  • THRM N/A
  • GERN $194.54
  • Revenue Next Year
  • THRM $4.83
  • GERN $56.51
  • P/E Ratio
  • THRM $16.68
  • GERN N/A
  • Revenue Growth
  • THRM N/A
  • GERN 22264.04
  • 52 Week Low
  • THRM $22.75
  • GERN $1.17
  • 52 Week High
  • THRM $56.68
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • THRM 54.25
  • GERN 32.46
  • Support Level
  • THRM $25.47
  • GERN $1.34
  • Resistance Level
  • THRM $27.09
  • GERN $1.44
  • Average True Range (ATR)
  • THRM 1.12
  • GERN 0.10
  • MACD
  • THRM 0.42
  • GERN 0.00
  • Stochastic Oscillator
  • THRM 85.53
  • GERN 3.23

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: